Aktiesnakken — August 2011
-
novo er en meget dygtig virksomhed, men multiplerne bliver meget anstrengt hvis væksten løjer af
-
og i det her marked skal der leveres ved kasse A
-
så kom der fart i Pandora..
-
ja det er måske en rimelig pe, men meget pharma handles til 14-15 pe
-
54-58 er mit gæt
-
jeg syntes at dagens kursstigning snart er forsvundet..
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind